Palatin Technologies
PTN
#10823
Rank
โ‚น1.55 B
Marketcap
โ‚น871.99
Share price
-5.36%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚น0.57 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น12.88 Million. In 2025 the company made an earning of -โ‚น0.94 Billion, an increase over its 2024 earnings that were of -โ‚น2.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.57 Billion-39.75%
2025 -โ‚น0.94 Billion-64.29%
2024 -โ‚น2.61 Billion-16.9%
2023 -โ‚น3.14 Billion5.99%
2022 -โ‚น2.97 Billion-13.7%
2021 -โ‚น3.43 Billion33.25%
2020 -โ‚น2.58 Billion-172.11%
2019 โ‚น3.56 B2352.33%
2018 โ‚น0.14 B-94.13%
2017 โ‚น2.48 B-154.92%
2016 -โ‚น4.52 Billion3.67%
2015 -โ‚น4.36 Billion878%
2014 -โ‚น0.45 Billion-72.64%
2013 -โ‚น1.63 Billion-33.11%
2012 -โ‚น2.44 Billion77.71%
2011 -โ‚น1.37 Billion
2003 -โ‚น2.32 Billion29.93%
2002 -โ‚น1.79 Billion36.18%
2001 -โ‚น1.32 Billion
1999 -โ‚น1.09 Billion6.04%
1998 -โ‚น1.03 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.536 T-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.387 T-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น79.19 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น1.05 Billion 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น23.62 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.39 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น13.80 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.86 Billion 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.37 Billion 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA